Critical Medicines Lists in Japan and the European Union: Insights into Supply Resilience and Policy Priorities.

Izutsu KI, Sasaki S, Kondo R, Namiki K, Uzawa H, Mamiya H

Open source

DOI
10.1248/bpb.b26-00220
Published
2026
Container
Biological & pharmaceutical bulletin
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1248/bpb.b26-00220,
  title = {Critical Medicines Lists in Japan and the European Union: Insights into Supply Resilience and Policy Priorities.},
  author = {Izutsu KI and Sasaki S and Kondo R and Namiki K and Uzawa H and Mamiya H},
  year = {2026},
  journal = {Biological \& pharmaceutical bulletin},
  doi = {10.1248/bpb.b26-00220},
  url = {https://doi.org/10.1248/bpb.b26-00220}
}

RIS

TY  - JOUR
TI  - Critical Medicines Lists in Japan and the European Union: Insights into Supply Resilience and Policy Priorities.
AU  - Izutsu KI
AU  - Sasaki S
AU  - Kondo R
AU  - Namiki K
AU  - Uzawa H
AU  - Mamiya H
PY  - 2026
JO  - Biological & pharmaceutical bulletin
DO  - 10.1248/bpb.b26-00220
UR  - https://doi.org/10.1248/bpb.b26-00220
ER  - 

APA

KI, I., S, S., R, K., K, N., H, U., & H, M. (2026). Critical Medicines Lists in Japan and the European Union: Insights into Supply Resilience and Policy Priorities.. Biological & pharmaceutical bulletin. https://doi.org/10.1248/bpb.b26-00220

Source records